Atlas Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Atlas Wealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.03M	Sell	4,048 -5	-0.1%	-$2.4K	0.29%	74
2026 Q1	$1.99M	Sell	4,053 -26	-0.6%	-$14.1K	0.6%	46
2025 Q4	$2.36M	Sell	4,079 -12	-0.3%	-$6.79K	0.72%	43
2025 Q3	$1.98M	Sell	4,091 -50	-1%	-$23.3K	0.64%	44
2025 Q2	$1.75M	Hold	4,141	–	–	0.64%	37
2025 Q1	$2.06M	Sell	4,141 -26	-0.6%	-$14.1K	0.8%	30
2024 Q4	$2.17M	Sell	4,167 -100	-2%	-$55K	0.82%	32
2024 Q3	$2.64M	Sell	4,267 -5,669	-57%	-$3.36M	1.14%	23
2024 Q2	$5.32M	Buy	9,936 +4,965	+100%	+$2.84M	0.63%	45
2024 Q1	$2.89M	Sell	4,971 -123	-2%	-$69K	1.41%	18
2023 Q4	$2.58M	Hold	5,094	–	–	1.4%	18
2023 Q3	$2.58M	Sell	5,094 -200	-4%	-$107K	0.48%	47
2023 Q2	$2.77M	Sell	5,294 -55	-1%	-$29.7K	0.51%	45
2023 Q1	$3.08M	Sell	5,349 -127	-2%	-$71.6K	0.61%	43
2022 Q4	$3.02M	Buy	+5,476	New	+$2.9M	0.81%	31

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Atlas Wealth's TMO Position: Q2 2026 in Review

Atlas Wealth reduced its Thermo Fisher Scientific (TMO) stake by 0.12% in Q2 2026, selling an estimated $2.4K and leaving 4,048 shares worth $2.03M. The position accounts for 0.29% of the portfolio, ranked #74.

Atlas Wealth first reported a position in TMO in Q4 2022 and has held it in 15 quarters since. The position peaked at $5.32M in Q2 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Atlas Wealth held 4,048 shares of Thermo Fisher Scientific worth $2.03M as of Q2 2026.
Atlas Wealth sold 5 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.4K.
Thermo Fisher Scientific made up 0.29% of Atlas Wealth's portfolio in Q2 2026, its #74 holding.
Atlas Wealth first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 15 quarters since.
Atlas Wealth's Thermo Fisher Scientific position peaked at $5.32M in Q2 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Atlas Wealth's 13F filing for Q2 2026, filed 28 Jul 2026.